Biocorrx (BICX) Expected to Announce Earnings on Thursday

Biocorrx (OTCMKTS:BICX) is expected to be issuing its results before the market opens on Thursday, November 13th. Analysts expect the company to announce earnings of ($0.06) per share for the quarter.

Biocorrx (OTCMKTS:BICX) last released its quarterly earnings data on Thursday, August 14th. The company reported ($0.07) earnings per share for the quarter. The firm had revenue of $0.18 million during the quarter.

Biocorrx Stock Performance

Shares of Biocorrx stock opened at $0.46 on Wednesday. Biocorrx has a 52-week low of $0.20 and a 52-week high of $1.45. The company’s 50 day moving average price is $0.40 and its 200-day moving average price is $0.37. The stock has a market capitalization of $9.29 million, a price-to-earnings ratio of -1.31 and a beta of 0.07.

Wall Street Analyst Weigh In

Separately, Zacks Research raised shares of Biocorrx to a “hold” rating in a report on Tuesday, September 2nd. One analyst has rated the stock with a Hold rating, Based on data from MarketBeat, Biocorrx presently has an average rating of “Hold”.

About Biocorrx

BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.